IGEA Pharma N.V. / Key word(s): Agreement/Agreement08-Jun-2022 / 00:14 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.IGEA PHARMA HAS SIGNED A PRELIMINARY AGREEMENT WITH LMH-AN INDUSTRIAL HOLDING COMPANY-FOR A EURO 6.000.000 COMMI.
IGEA Pharma N.V. / Key word(s): Agreement/Agreement IGEA Pharma N.V.: IGEA PHARMA HAS SIGNED A PRELIMINARY AGREEMENT WITH LMH-AN INDUSTRIAL HOLDING COMPANY-FOR A EURO 6.000.000 COMMITTMENT TO FUND
08.06.2022 - IGEA Pharma N.V. / Key word(s): Agreement/Agreement IGEA Pharma N.V.: IGEA PHARMA HAS SIGNED A PRELIMINARY AGREEMENT WITH LMH-AN INDUSTRIAL HOLDING COMPANY-FOR A EURO 6.000.000 COMMITTMENT TO FUND THE COMPLETION OF ITS SWISS CBD EXTRACTION FACILITY . Seite 1
IGEA Pharma N.V. / Key word(s): Agreement/Agreement IGEA Pharma N.V.: IGEA PHARMA HAS SIGNED A PRELIMINARY AGREEMENT WITH LMH-AN INDUSTRIAL HOLDING COMPANY-FOR A EURO 6.000.000 COMMITTMENT TO FUND
Original-Research: IGEA Pharma N.V. - von GBC AG Einstufung von GBC AG zu IGEA Pharma N.V. Unternehmen: IGEA Pharma N.V. ISIN: NL0012768675 Anlass der Studie: Research Report (Initial Coverage)